Age- and Tumor Subtype–Specific Breast Cancer Risk Estimates for <i>CH</i><i>EK</i><i>2</i>*1100delC Carriers
Marjanka K. Schmidt(University of Cambridge), Andrew Lee(University of Cambridge), Richard van Hien(University of Copenhagen), Volker Arndt(German Cancer Research Center), Angela Cox, H Meijers(Roche (Switzerland)), Hiltrud Brauch(German Cancer Research Center), Natalia Bogdanova(Medizinische Hochschule Hannover), Thomas Brüning(Institute for Prevention and Occupational Medicine), Fergus J. Couch(Mayo Clinic), Peter A. Fasching(Universitätsklinikum Erlangen), Graham G. Giles(The University of Melbourne), Eva Galle(ETH Zurich), Jenny Chang‐Claude(Universität Hamburg), Simon S. Cross(University of Sheffield), Michael E. Jones(Institute of Cancer Research), Jonine D. Figueroa, Annegien Broeks, Quinten Waisfisz(University Medical Center Utrecht), Antonis C. Antoniou(Weatherford College), Alison M. Dunning(University of Cambridge), Kamila Czene(Karolinska Institutet), Georgia Chenevix‐Trench(QIMR Berghofer Medical Research Institute), Esther M. John, Irene L. Andrulis(University of Toronto), Per Hall(Karolinska Institutet), Antoinette Hollestelle(Erasmus MC Cancer Institute), Anna Jakubowska(Pomeranian Medical University), Э. К. Хуснутдинова(Russian Academy of Sciences), Olivia Fletcher(Breast Cancer Care), Sten Cornelissen(Roche (Switzerland)), Montserrat García‐Closas(Institute of Cancer Research), Hermann Brenner(Universidad de Granada), Hoda Anton‐Culver(University of California, Irvine), Muriel A. Adank(The Netherlands Cancer Institute), Julia A. Knight, Ans van den Ouweland(Roche (Switzerland)), Barbara Burwinkel(German Cancer Research Center), Natalia Antonenkova(N.N. Alexandrov National Cancer Centre), Frans B.L. Hogervorst(The Netherlands Cancer Institute), John L. Hopper(The University of Melbourne), Maartje J. Hooning(University of Copenhagen), Vessela Kristensen(Roche (Switzerland)), Veli‐Matti Kosma(University of Eastern Finland), Henrik Flyger(Herlev Hospital), Manjeet K. Bolla(University of Cambridge), Lothar Haeberle(Friedrich-Alexander-Universität Erlangen-Nürnberg), Peter Hillemanns(Medizinische Hochschule Hannover), Mieke Schutte(Erasmus MC), Marina Bermisheva(Russian Academy of Sciences)
Cited by 181
Related Papers
Mutations of the BRAF gene in human cancer
|Nature|2002|10.7k
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015
|JAMA Oncology|2016|6.3k
Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019
|The Lancet Public Health|2022|5.4k
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
|The Lancet|2014|4.7k
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
|The American Journal of Human Genetics|2003|3.7k